Belicario, Bb Girl .

HRN: 21-83-24  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/25/2022
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
08/25/2022
09/01/2022
IV
42 Mg
Q24 H
MSAF Thickly, Maternal UTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: